0001764013-21-000108.txt : 20211018
0001764013-21-000108.hdr.sgml : 20211018
20211018171111
ACCESSION NUMBER: 0001764013-21-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211015
FILED AS OF DATE: 20211018
DATE AS OF CHANGE: 20211018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barnett Eva Renee
CENTRAL INDEX KEY: 0001883766
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38906
FILM NUMBER: 211328861
MAIL ADDRESS:
STREET 1: C/O IMMUNOVANT, INC.
STREET 2: 320 WEST 37TH STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunovant, Inc.
CENTRAL INDEX KEY: 0001764013
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 832771572
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 917-580-3099
MAIL ADDRESS:
STREET 1: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Health Sciences Acquisitions Corp
DATE OF NAME CHANGE: 20190108
4
1
wf-form4_163459145674723.xml
FORM 4
X0306
4
2021-10-15
0
0001764013
Immunovant, Inc.
IMVT
0001883766
Barnett Eva Renee
C/O IMMUNOVANT, INC.
320 W 37TH STREET, 6TH FLOOR
NEW YORK
NY
10018
0
1
0
0
Chief Financial Officer
Common Stock
2021-10-15
4
A
0
143000
0
A
202500
D
Stock Option (right to buy)
8.72
2021-10-15
4
A
0
333000
0
A
2031-10-15
Common Stock
333000.0
333000
D
Represents the number of shares underlying restricted stock units awards ("RSUs").
The RSUs vest over four years, with 25% of the RSUs vesting on October 4, 2022 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on October 4, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
/s/ Eva Renee Barnett
2021-10-18